Don’t overprescribe monkeypox treatment, FDA warns physicians

The number of prescriptions for monkeypox antiviral Tpoxx should be “judicious” because virus mutations can make it ineffective, the FDA said in an updated monkeypox guidance Sept. 14. 

Read the full post on Becker's Hospital Review - Healthcare News